...
...
Next Story

India's Ranbaxy gets US FDA nod for ramipril

Indian drug maker Ranbaxy Laboratories Ltd said on Monday it had received approval from the US Food and Drug Administration to manufacture and market ramipril capsules.

Updated on: Mar 09, 2009 10:15 AM IST
Advertisement

Indian drug maker Ranbaxy Laboratories Ltd said on Monday it had received approval from the US Food and Drug Administration to manufacture and market ramipril capsules.

HT Image
HT Image

Ramipril is used in the treatment of cardiovalscular diseases.

 
SHARE THIS ARTICLE ON
Hindustantimes wants to start sending you push notifications. Click allow to subscribe